Skip to main content

Table 2 Composition of Lumefantrine LSES using Kolliphor EL as surfactant component

From: Solubility enhancing lipid-based vehicles for artemether and lumefantrine destined for the possible treatment of induced malaria and inflammation: in vitro and in vivo evaluations

Ratio (O:S:C)

Oil (oleic acid) ml

Surfactant (kolliphor EL) ml

Co-surfactant (lauroglycol) ml

Kollidon VA 64 (mg)

34:50:16

0.34

0.41

0.16

100

34:55:11

0.34

0.45

0.11

100

34:60:04

0.34

0.49

0.06

100

34:65:01

0.34

0.54

0.01

100